Crescendo Biologics Limited Sustainability Profile
Crescendo Biologics Limited, a pioneering biopharmaceutical company based in Great Britain, focuses on the development of innovative therapeutic solutions. Founded in 2008, Crescendo has established itself in the biotechnology industry, specialising in the creation of unique, fully human monoclonal antibodies and biologics. With a strong emphasis on its proprietary VH domain technology, the company aims to address unmet medical needs in oncology and autoimmune diseases. Crescendo's commitment to advancing biologics has positioned it as a notable player in the market, with significant achievements in drug development and strategic partnerships. As it continues to expand its operational reach, Crescendo Biologics remains dedicated to delivering cutting-edge therapies that enhance patient outcomes.
DitchCarbon Score
How does Crescendo Biologics Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Crescendo Biologics Limited's score of 26 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Crescendo Biologics Limited's reported carbon emissions
Crescendo Biologics Limited, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As such, Crescendo Biologics Limited has not established any significant commitments towards reducing its carbon footprint or addressing climate change at this time. Without emissions data or reduction initiatives, it is unclear how the company aligns with industry standards for sustainability and climate action.
How Carbon Intensive is Crescendo Biologics Limited's Industry?
How Carbon Intensive is Crescendo Biologics Limited's Location?
Crescendo Biologics Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Crescendo Biologics Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
